Johnson & Johnson vaccine could raise rare neurological disorder risk, FDA warns
Johnson & Johnson was in talks with the U.S. Food and Drug Administration and Centers for Disease Control and Prevention ...
Read moreJohnson & Johnson was in talks with the U.S. Food and Drug Administration and Centers for Disease Control and Prevention ...
Read moreVaccine makers, Pfizer and Moderna, are now aiming to provide COVID-19 boosters. But, health organizations and agencies are seemingly discouraging ...
Read moreThe news that Pfizer’s COVID-19 vaccine has gained emergency approval in the United Kingdom and may be distributed to selected ...
Read moreRemdesivir drug receives approval as a treatment medicine for COVID-19 patients. The US Food and Drug Administration (FDA) approves the ...
Read moreLack of study for convalescent plasma as treatment prompts scientists to question the Food and Drug Association's grant to use ...
Read moreThe U.S. Food and Drug Administration (FDA) defended the reliability of COVID-19 antibody tests, saying that false results only recognize ...
Read moreMultiple companies are recently engaged in a blockchain effort that will create an infrastructure to help verify and track pharmaceutical ...
Read moreAfter weeks of waiting, the Philippines' Food and Drug Administration has finally approved a locally-made rapid test kit, which promises ...
Read moreEverlyWell, a digital health company specializing in at-home test kits, has come up with a solution to alleviate the ongoing ...
Read moreAs a news and media company, our focus is on bringing you the latest news and information from the blockchain, gaming, technology, entertainment, and business industries.
Before reading any material on this website, it is a requirement to read “Terms and Conditions” and “Privacy Policy“ first. By reading or interacting with any of our content, website or social media you agree to be bound by these. This includes, but not limited to the public, consumers, readers & advertisers. Micky is a news site and does not provide trading, investing, or other financial advice. By using this website, you affirm that you have read and agree to abide by our Terms and Conditions